Enzo Biochem at the end of the month will present for the first time peer-reviewed data on detection of hepatitis C virus using its new AmpiProbe nucleic acid amplification chemistry, the company said today.

At the European Society of Clinical Microbiology and Infectious Disease annual meeting, scheduled to take place March 31-April 3 in London, Enzo scientists will present a study entitled "Quantitative Detection of HCV RNA in Human Plasma-Serum using the Enzo AmpiProbe HCV RNA Assay."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.